A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
NCT ID: NCT01070433
Last Updated: 2025-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
75 participants
INTERVENTIONAL
2012-09-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
NCT01154374
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
NCT01138436
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
NCT02326337
Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers
NCT01291160
A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot
NCT04564443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MEBO Wound Ointment (MEBO)
Topical application twice a day
MEBO Wound Ointment (MEBO)
Topical application twice a day
Standard of Care
Topical application twice a day
Standard of Care
Topical application twice a day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MEBO Wound Ointment (MEBO)
Topical application twice a day
Standard of Care
Topical application twice a day
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able and willing to provide informed consent
* Able and willing to comply with protocol visits and procedures
* Target ulcer duration of ≥4 weeks
Exclusion Criteria
* Known or suspected allergies to any of the components of MEBO
* Malignancy on target ulcer foot
* Non-compliance in the screening or run-in period
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Skingenix, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert S Kirsner, MD, PhD
Role: STUDY_CHAIR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HOPE Research Institute
Phoenix, Arizona, United States
Center for Clinical Research, Inc.
Castro Valley, California, United States
ILD Consulting, Inc.
Encinitas, California, United States
Sacramento Foot and Ankle Center
Fair Oaks, California, United States
Valley Vascular Surgery Associates
Fresno, California, United States
Foot and Ankle Clinic
Los Angeles, California, United States
Advanced Foot and Ankle Center
Las Vegas, Nevada, United States
Complete Family Foot Care
McAllen, Texas, United States
Endeavor Clinical Trials, San Antonio Podiatry Associates
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEBO-DFU-PII-001 v. 4.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.